SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics Monthly Activity About

SEC Company Response from Tilray Brands, (TLRY) — Mar 13, 2026

Tilray Brands, Inc.
Date: March 13, 2026 · CIK: 0001731348 · Accession: 0001437749-26-008133

Financial Reporting Revenue Recognition Regulatory Compliance

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 001-38594

Date
March 13, 2026
Author
By: /s/ Carl A. Merton
Form
CORRESP
Company
Tilray Brands, Inc.

Letter

United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences Re: Tilray Brands, Inc. Form 10-K for the fiscal year ended May 31, 2025 Form 10-Q for the quarterly period ended August 31, 2025 File No. 001-38594

Dear Ms. Do and Mr. Gordon,

On behalf of Tilray Brands, Inc. (“Tilray”, “we”, or the “Company”), we respectfully submit the below in response to the comment received from the Division of Corporate Finance of the Securities and Exchange Commission (the “Staff”) in connection with your review of Tilray’s Form 10-K for the fiscal year ended May 31, 2025 (the “Form 10-K”) and Form 10-Q for the fiscal quarter ended August 31, 2025 (the “Comment”). For the Staff’s convenience, we have recited the Comment in this response letter.

Form 10-Q for the quarterly period ended August 31, 2025

Management ’ s Discussion and Analysis of Financial Condition and Results of Operations, page 25

Results of Operations, page 28

1.

We have read your response to comment one. Please further revise your future filings as applicable to highlight that the change in fair value of contingent consideration of $15.0 million recognized during the three months ended August 31, 2025, resulted in net income for the period then ended, when we note you historically report a net loss.

We appreciate the Staff’s comment and respectfully submit that we will revise our future filings pursuant to your comment above.

Please do not hesitate to contact me at carl.merton@tilray.com if you have any questions or would like any additional information regarding this matter.

Sincerely,
By: /s/ Carl A. Merton

Show Raw Text
CORRESP
 1
 filename1.htm

 tlry20260313_corresp.htm

 March 13, 2026

 United States Securities and Exchange Commission

 Division of Corporation Finance

 Office of Life Sciences

 100 F Street, N.E.

 Washington, D.C. 20549

 Attn: Jenn Do and Daniel Gordon

 Re: Tilray Brands, Inc.

 Form 10-K for the fiscal year ended May 31, 2025

 Form 10-Q for the quarterly period ended August 31, 2025

 File No. 001-38594

 Dear Ms. Do and Mr. Gordon,

 On behalf of Tilray Brands, Inc. (“Tilray”, “we”, or the “Company”), we respectfully submit the below in response to the comment received from the Division of Corporate Finance of the Securities and Exchange Commission (the “Staff”) in connection with your review of Tilray’s Form 10-K for the fiscal year ended May 31, 2025 (the “Form 10-K”) and Form 10-Q for the fiscal quarter ended August 31, 2025 (the “Comment”). For the Staff’s convenience, we have recited the Comment in this response letter.

 Form 10-Q for the quarterly period ended August 31, 2025

 Management ’ s Discussion and Analysis of Financial Condition and Results of Operations, page 25

 Results of Operations, page 28

 1.

 We have read your response to comment one. Please further revise your future filings as applicable to highlight that the change in fair value of contingent consideration of $15.0 million recognized during the three months ended August 31, 2025, resulted in net income for the period then ended, when we note you historically report a net loss.

 We appreciate the Staff’s comment and respectfully submit that we will revise our future filings pursuant to your comment above.

 Please do not hesitate to contact me at carl.merton@tilray.com if you have any questions or would like any additional information regarding this matter.

 Sincerely,

 By: /s/ Carl A. Merton

 Carl A. Merton

 Chief Financial Officer

 Tilray Brands, Inc.

 Cc: Mitchell Gendel – Global General Counsel